Kun for helsepersonell

Viktig sikkerhets-og forskrivningsinformasjon: Breyanzi® (lisocabtagene maraleucel)

image

Biomarkers in LBCL

Interview: 3 minutes

Professor Sirpa Leppä, Helsinki University Hospital, share the focus on studying biomarkers to guide physicians in selecting the most appropriate patients for treatment and how to potentially optimize treatment outcomes and minimize the risk of adverse events. 

 

Related videos

From Clinical Study To Clinical Practice with CAR-T
How can we improve outcomes for patients with R/R LBCL?

News

Learn about current topics in hematology, such as new research data, news from events, congresses and more.

Education

Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.

 

HE-SE-2500011 Oct 2025 video/ 2009-NO-2500020 Dec 2025